Literature DB >> 20211135

miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.

Anna M Eiring1, Jason G Harb, Paolo Neviani, Christopher Garton, Joshua J Oaks, Riccardo Spizzo, Shujun Liu, Sebastian Schwind, Ramasamy Santhanam, Christopher J Hickey, Heiko Becker, Jason C Chandler, Raul Andino, Jorge Cortes, Peter Hokland, Claudia S Huettner, Ravi Bhatia, Denis C Roy, Stephen A Liebhaber, Michael A Caligiuri, Guido Marcucci, Ramiro Garzon, Carlo M Croce, George A Calin, Danilo Perrotti.   

Abstract

MicroRNAs and heterogeneous ribonucleoproteins (hnRNPs) are posttranscriptional gene regulators that bind mRNA in a sequence-specific manner. Here, we report that loss of miR-328 occurs in blast crisis chronic myelogenous leukemia (CML-BC) in a BCR/ABL dose- and kinase-dependent manner through the MAPK-hnRNP E2 pathway. Restoration of miR-328 expression rescues differentiation and impairs survival of leukemic blasts by simultaneously interacting with the translational regulator poly(rC)-binding protein hnRNP E2 and with the mRNA encoding the survival factor PIM1, respectively. The interaction with hnRNP E2 is independent of the microRNA's seed sequence and it leads to release of CEBPA mRNA from hnRNP E2-mediated translational inhibition. Altogether, these data reveal the dual ability of a microRNA to control cell fate both through base pairing with mRNA targets and through a decoy activity that interferes with the function of regulatory proteins. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211135      PMCID: PMC2924756          DOI: 10.1016/j.cell.2010.01.007

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  45 in total

1.  Identification of PCBP2, a facilitator of IRES-mediated translation, as a novel constituent of stress granules and processing bodies.

Authors:  Ken Fujimura; Fumi Kano; Masayuki Murata
Journal:  RNA       Date:  2008-01-03       Impact factor: 4.942

2.  Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.

Authors:  Xabier Agirre; Antonio Jiménez-Velasco; Edurne San José-Enériz; Leire Garate; Eva Bandrés; Lucia Cordeu; Oscar Aparicio; Borja Saez; Germán Navarro; Amaia Vilas-Zornoza; Ignacio Pérez-Roger; Jesús García-Foncillas; Antonio Torres; Anabel Heiniger; María José Calasanz; Puri Fortes; José Román-Gómez; Felipe Prósper
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

3.  High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.

Authors:  Ji Suk Chang; Ramasamy Santhanam; Rossana Trotta; Paolo Neviani; Anna M Eiring; Edward Briercheck; Mattia Ronchetti; Denis C Roy; Bruno Calabretta; Michael A Caligiuri; Danilo Perrotti
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

Review 4.  Diverse molecular functions of Hu proteins.

Authors:  M N Hinman; H Lou
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

5.  Regulation of progenitor cell proliferation and granulocyte function by microRNA-223.

Authors:  Jonathan B Johnnidis; Marian H Harris; Robert T Wheeler; Sandra Stehling-Sun; Michael H Lam; Oktay Kirak; Thijn R Brummelkamp; Mark D Fleming; Fernando D Camargo
Journal:  Nature       Date:  2008-02-17       Impact factor: 49.962

6.  Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.

Authors:  Anna M Eiring; Paolo Neviani; Ramasamy Santhanam; Joshua J Oaks; Ji Suk Chang; Mario Notari; William Willis; Carlo Gambacorti-Passerini; Stefano Volinia; Guido Marcucci; Michael A Caligiuri; Gustavo W Leone; Danilo Perrotti
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

7.  Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression.

Authors:  María J Bueno; Ignacio Pérez de Castro; Marta Gómez de Cedrón; Javier Santos; George A Calin; Juan C Cigudosa; Carlo M Croce; José Fernández-Piqueras; Marcos Malumbres
Journal:  Cancer Cell       Date:  2008-06       Impact factor: 31.743

8.  The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a.

Authors:  Sonia Guil; Javier F Cáceres
Journal:  Nat Struct Mol Biol       Date:  2007-06-10       Impact factor: 15.369

Review 9.  RNA-binding proteins and post-transcriptional gene regulation.

Authors:  Tina Glisovic; Jennifer L Bachorik; Jeongsik Yong; Gideon Dreyfuss
Journal:  FEBS Lett       Date:  2008-03-13       Impact factor: 4.124

10.  MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression.

Authors:  Chia-Hui Wang; Daniel Y Lee; Zhaoqun Deng; Zina Jeyapalan; Shao-Chen Lee; Shireen Kahai; Wei-Yang Lu; Yaou Zhang; Burton B Yang
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  228 in total

1.  MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML.

Authors:  Sukanya Suresh; Lynn McCallum; Wanhua Lu; Noureddine Lazar; Bernard Perbal; Alexandra E Irvine
Journal:  J Cell Commun Signal       Date:  2011-06-03       Impact factor: 5.782

Review 2.  Spotlight on post-transcriptional control in the circadian system.

Authors:  Dorothee Staiger; Tino Köster
Journal:  Cell Mol Life Sci       Date:  2010-08-30       Impact factor: 9.261

Review 3.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

Review 4.  Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases.

Authors:  Patrick Provost
Journal:  Aging (Albany NY)       Date:  2010-03-31       Impact factor: 5.682

Review 5.  For better or for worse: the role of Pim oncogenes in tumorigenesis.

Authors:  Martijn C Nawijn; Andrej Alendar; Anton Berns
Journal:  Nat Rev Cancer       Date:  2010-12-09       Impact factor: 60.716

Review 6.  Cross talk between microRNA and coding cancer genes.

Authors:  Tanja Kunej; Irena Godnic; Simon Horvat; Minja Zorc; George A Calin
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

7.  p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.

Authors:  Marina Zemskova; Michael B Lilly; Ying-Wei Lin; Jin H Song; Andrew S Kraft
Journal:  Mol Cancer Res       Date:  2010-07-20       Impact factor: 5.852

Review 8.  MicroRNAs as therapeutic targets in human cancers.

Authors:  Maitri Y Shah; George A Calin
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-03-28       Impact factor: 9.957

9.  Changes in cellular mRNA stability, splicing, and polyadenylation through HuR protein sequestration by a cytoplasmic RNA virus.

Authors:  Michael D Barnhart; Stephanie L Moon; Alexander W Emch; Carol J Wilusz; Jeffrey Wilusz
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

Review 10.  MicroRNAs: history, biogenesis, and their evolving role in animal development and disease.

Authors:  M Bhaskaran; M Mohan
Journal:  Vet Pathol       Date:  2013-09-17       Impact factor: 2.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.